Industry: Medical Devices & Consumables
Published Date: 2025-09-08
Pages: 107 Pages
Report ld: 3432377
Request Sample
Customized Report
Organ On Chip Market Size(US$)

CAGR 2025-2031
30.2%
Market Size,2031
USD 1,076
Million
Market Snapshot
Source: Secondary research, interviews with experts, and QYResearch analysis
The global market for Organ On Chip was valued at US$ 166 million in the year 2024 and is projected to reach a revised size of US$ 1076 million by 2031, growing at a CAGR of 30.2% during the forecast period.
A Organ on Chip is a small-scale device that replicates the mechanical and biological properties of human organs. These chips contain tiny channels lined with living human cells that form tissue layers. They can simulate the physiology of various organs, such as the heart, liver, lungs, kidneys, and intestines, allowing researchers to better understand organ-specific functions and diseases. These models are typically made using microfluidic technology, where human cells are cultured in a small, transparent chip, allowing researchers to simulate organ-specific functions and study disease processes, drug responses, and more. By offering more accurate, scalable, and human-relevant data, Human Organs-on-Chips are revolutionizing biomedical research and drug testing, providing a bridge between traditional animal models and human clinical trials.
The organ-on-a-chip market is primarily driven by the growing demand for more efficient, accurate, and ethically compliant in vitro biological models. Traditional drug development methods are often costly, time-consuming, and have low clinical translation success rates. In contrast, organ-on-a-chip technology, which closely mimics the microenvironment and functions of human organs, offers a promising alternative to improve drug screening efficiency and predictive accuracy. Increasing restrictions on animal testing, especially in regions like North America and Europe, are also accelerating the adoption of advanced alternatives that align with the "3Rs" principle—Replacement, Reduction, and Refinement—making organ-on-a-chip an ethically favorable solution. Furthermore, the rise of personalized and precision medicine is driving the use of patient-derived cells in organ chips for individualized drug testing and response prediction. Technological advancements across regenerative medicine, immunotherapy, and bioengineering are supporting the diversification and platformization of organ chip systems. In addition, sustained investment from both the public and private sectors in biotechnology is facilitating the commercialization of organ-on-a-chip platforms. As multi-organ chips evolve and integrate with AI, biosensors, and other digital health technologies, the market is expected to see rapid growth across high-value applications such as drug discovery, toxicity testing, and disease modeling.
Global main manufacturers of organ-on-chip include Emulate, Mimetas and TissUse, etc. The top three players hold a share about 40%. The global organ-on-chip is mainly produced in United States and Europe, they occupied for a share over 80%. North America is the largest market, has a share about 43%, followed by Europe and Japan, with share 37% and 8%, separately.
This report aims to provide a comprehensive presentation of the global market for Organ On Chip, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Organ On Chip.
The Organ On Chip market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Organ On Chip market comprehensively. Regional market sizes, concerning products by Type, by End User, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Organ On Chip companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by End User, and by regions.
MARKET SEGMENTATION
CHAPTER OUTLINE
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by End User, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Organ On Chip company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by End User, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Organ On Chip Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Brain-on-a-chip
1.2.3 Liver-on-a-chip
1.2.4 Kidney-on-a-chip
1.2.5 Lung-on-a-chip
1.2.6 Heart-on-a-chip
1.2.7 Intestine-on-a-chip
1.2.8 Vessel-on-a-chip
1.2.9 Other Organs
1.3 Market by End User
1.3.1 Global Organ On Chip Market Growth by End User: 2020 VS 2024 VS 2031
1.3.2 Pharmaceutical & Biotechnology Companies
1.3.3 Academic & Research Institutes
1.3.4 Cosmetics Industry
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Organ On Chip Market Perspective (2020-2031)
2.2 Global Organ On Chip Growth Trends by Region
2.2.1 Global Organ On Chip Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Organ On Chip Historic Market Size by Region (2020-2025)
2.2.3 Organ On Chip Forecasted Market Size by Region (2026-2031)
2.3 Organ On Chip Market Dynamics
2.3.1 Organ On Chip Industry Trends
2.3.2 Organ On Chip Market Drivers
2.3.3 Organ On Chip Market Challenges
2.3.4 Organ On Chip Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Organ On Chip Players by Revenue
3.1.1 Global Top Organ On Chip Players by Revenue (2020-2025)
3.1.2 Global Organ On Chip Revenue Market Share by Players (2020-2025)
3.2 Global Top Organ On Chip Players by Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Organ On Chip Revenue
3.4 Global Organ On Chip Market Concentration Ratio
3.4.1 Global Organ On Chip Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Organ On Chip Revenue in 2024
3.5 Global Key Players of Organ On Chip Head office and Area Served
3.6 Global Key Players of Organ On Chip, Product and Application
3.7 Global Key Players of Organ On Chip, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Organ On Chip Breakdown Data by Type
4.1 Global Organ On Chip Historic Market Size by Type (2020-2025)
4.2 Global Organ On Chip Forecasted Market Size by Type (2026-2031)
5 Organ On Chip Breakdown Data by End User
5.1 Global Organ On Chip Historic Market Size by End User (2020-2025)
5.2 Global Organ On Chip Forecasted Market Size by End User (2026-2031)
6 North America
6.1 North America Organ On Chip Market Size (2020-2031)
6.2 North America Organ On Chip Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Organ On Chip Market Size by Country (2020-2025)
6.4 North America Organ On Chip Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Organ On Chip Market Size (2020-2031)
7.2 Europe Organ On Chip Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Organ On Chip Market Size by Country (2020-2025)
7.4 Europe Organ On Chip Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Ireland
8 Asia-Pacific
8.1 Asia-Pacific Organ On Chip Market Size (2020-2031)
8.2 Asia-Pacific Organ On Chip Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Organ On Chip Market Size by Region (2020-2025)
8.4 Asia-Pacific Organ On Chip Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia & New Zealand
9 Latin America
9.1 Latin America Organ On Chip Market Size (2020-2031)
9.2 Latin America Organ On Chip Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Organ On Chip Market Size by Country (2020-2025)
9.4 Latin America Organ On Chip Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Organ On Chip Market Size (2020-2031)
10.2 Middle East & Africa Organ On Chip Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Organ On Chip Market Size by Country (2020-2025)
10.4 Middle East & Africa Organ On Chip Market Size by Country (2026-2031)
10.5 Israel
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Emulate
11.1.1 Emulate Company Details
11.1.2 Emulate Business Overview
11.1.3 Emulate Organ On Chip Introduction
11.1.4 Emulate Revenue in Organ On Chip Business (2020-2025)
11.1.5 Emulate Recent Development
11.2 Mimetas
11.2.1 Mimetas Company Details
11.2.2 Mimetas Business Overview
11.2.3 Mimetas Organ On Chip Introduction
11.2.4 Mimetas Revenue in Organ On Chip Business (2020-2025)
11.2.5 Mimetas Recent Development
11.3 TissUse
11.3.1 TissUse Company Details
11.3.2 TissUse Business Overview
11.3.3 TissUse Organ On Chip Introduction
11.3.4 TissUse Revenue in Organ On Chip Business (2020-2025)
11.3.5 TissUse Recent Development
11.4 Valo Health
11.4.1 Valo Health Company Details
11.4.2 Valo Health Business Overview
11.4.3 Valo Health Organ On Chip Introduction
11.4.4 Valo Health Revenue in Organ On Chip Business (2020-2025)
11.4.5 Valo Health Recent Development
11.5 CN Bio Innovations
11.5.1 CN Bio Innovations Company Details
11.5.2 CN Bio Innovations Business Overview
11.5.3 CN Bio Innovations Organ On Chip Introduction
11.5.4 CN Bio Innovations Revenue in Organ On Chip Business (2020-2025)
11.5.5 CN Bio Innovations Recent Development
11.6 Hesperos
11.6.1 Hesperos Company Details
11.6.2 Hesperos Business Overview
11.6.3 Hesperos Organ On Chip Introduction
11.6.4 Hesperos Revenue in Organ On Chip Business (2020-2025)
11.6.5 Hesperos Recent Development
11.7 Draper Laboratory
11.7.1 Draper Laboratory Company Details
11.7.2 Draper Laboratory Business Overview
11.7.3 Draper Laboratory Organ On Chip Introduction
11.7.4 Draper Laboratory Revenue in Organ On Chip Business (2020-2025)
11.7.5 Draper Laboratory Recent Development
11.8 Nortis
11.8.1 Nortis Company Details
11.8.2 Nortis Business Overview
11.8.3 Nortis Organ On Chip Introduction
11.8.4 Nortis Revenue in Organ On Chip Business (2020-2025)
11.8.5 Nortis Recent Development
11.9 Micronit Microtechnologies B.V.
11.9.1 Micronit Microtechnologies B.V. Company Details
11.9.2 Micronit Microtechnologies B.V. Business Overview
11.9.3 Micronit Microtechnologies B.V. Organ On Chip Introduction
11.9.4 Micronit Microtechnologies B.V. Revenue in Organ On Chip Business (2020-2025)
11.9.5 Micronit Microtechnologies B.V. Recent Development
11.10 Kirkstall
11.10.1 Kirkstall Company Details
11.10.2 Kirkstall Business Overview
11.10.3 Kirkstall Organ On Chip Introduction
11.10.4 Kirkstall Revenue in Organ On Chip Business (2020-2025)
11.10.5 Kirkstall Recent Development
11.11 Cherry Biotech SAS
11.11.1 Cherry Biotech SAS Company Details
11.11.2 Cherry Biotech SAS Business Overview
11.11.3 Cherry Biotech SAS Organ On Chip Introduction
11.11.4 Cherry Biotech SAS Revenue in Organ On Chip Business (2020-2025)
11.11.5 Cherry Biotech SAS Recent Development
11.12 Else Kooi Laboratory
11.12.1 Else Kooi Laboratory Company Details
11.12.2 Else Kooi Laboratory Business Overview
11.12.3 Else Kooi Laboratory Organ On Chip Introduction
11.12.4 Else Kooi Laboratory Revenue in Organ On Chip Business (2020-2025)
11.12.5 Else Kooi Laboratory Recent Development
11.13 Altis Biosystems
11.13.1 Altis Biosystems Company Details
11.13.2 Altis Biosystems Business Overview
11.13.3 Altis Biosystems Organ On Chip Introduction
11.13.4 Altis Biosystems Revenue in Organ On Chip Business (2020-2025)
11.13.5 Altis Biosystems Recent Development
11.14 Bi/ond
11.14.1 Bi/ond Company Details
11.14.2 Bi/ond Business Overview
11.14.3 Bi/ond Organ On Chip Introduction
11.14.4 Bi/ond Revenue in Organ On Chip Business (2020-2025)
11.14.5 Bi/ond Recent Development
11.15 Netri
11.15.1 Netri Company Details
11.15.2 Netri Business Overview
11.15.3 Netri Organ On Chip Introduction
11.15.4 Netri Revenue in Organ On Chip Business (2020-2025)
11.15.5 Netri Recent Development
11.16 Xona Microfluidics
11.16.1 Xona Microfluidics Company Details
11.16.2 Xona Microfluidics Business Overview
11.16.3 Xona Microfluidics Organ On Chip Introduction
11.16.4 Xona Microfluidics Revenue in Organ On Chip Business (2020-2025)
11.16.5 Xona Microfluidics Recent Development
11.17 SynVivo, Inc.
11.17.1 SynVivo, Inc. Company Details
11.17.2 SynVivo, Inc. Business Overview
11.17.3 SynVivo, Inc. Organ On Chip Introduction
11.17.4 SynVivo, Inc. Revenue in Organ On Chip Business (2020-2025)
11.17.5 SynVivo, Inc. Recent Development
11.18 Beijing Daxiang Biotech
11.18.1 Beijing Daxiang Biotech Company Details
11.18.2 Beijing Daxiang Biotech Business Overview
11.18.3 Beijing Daxiang Biotech Organ On Chip Introduction
11.18.4 Beijing Daxiang Biotech Revenue in Organ On Chip Business (2020-2025)
11.18.5 Beijing Daxiang Biotech Recent Development
11.19 AVATARGET
11.19.1 AVATARGET Company Details
11.19.2 AVATARGET Business Overview
11.19.3 AVATARGET Organ On Chip Introduction
11.19.4 AVATARGET Revenue in Organ On Chip Business (2020-2025)
11.19.5 AVATARGET Recent Development
11.20 Suzhou Jiyan Biopharmaceutical
11.20.1 Suzhou Jiyan Biopharmaceutical Company Details
11.20.2 Suzhou Jiyan Biopharmaceutical Business Overview
11.20.3 Suzhou Jiyan Biopharmaceutical Organ On Chip Introduction
11.20.4 Suzhou Jiyan Biopharmaceutical Revenue in Organ On Chip Business (2020-2025)
11.20.5 Suzhou Jiyan Biopharmaceutical Recent Development
11.21 InSphero
11.21.1 InSphero Company Details
11.21.2 InSphero Business Overview
11.21.3 InSphero Organ On Chip Introduction
11.21.4 InSphero Revenue in Organ On Chip Business (2020-2025)
11.21.5 InSphero Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
TABLE OF FIGURES
List of Tables
List of Figures
KEY QUESTIONS ADDRESSED BY THE REPORT
Related Reports
The global Organ On Chip market is projected to grow from US$ 221 million in 2025 to US$ 1368 million by 2032, at a CAGR of 30.2% (2026-2032), driven by critical product segments and diverse end‑use applications.
Published Date: 2026-08-15
Pages: 174
USD 4900.00
(Single User License)
The global Organ On Chip market size was US$ 221 million in 2025 and is forecast to reach a readjusted size of US$ 1368 million by 2032 with a CAGR of 30.2% during the forecast period 2026-2032.
Published Date: 2026-08-15
Pages: 141
USD 4250.00
(Single User License)
The global Organ On Chip market was valued at US$ 221 million in 2025 and is anticipated to reach US$ 1368 million by 2032, at a CAGR of 30.2% from 2026 to 2032.
Published Date: 2026-08-15
Pages: 160
USD 2900.00
(Single User License)
The global market for Organ On Chip was estimated to be worth US$ 221 million in 2025 and is projected to reach US$ 1368 million, growing at a CAGR of 30.2% from 2026 to 2032.
Published Date: 2026-08-15
Pages: 147
USD 3950.00
(Single User License)
The global market for Organ On Chip was estimated to be worth US$ 166 million in 2024 and is forecast to a readjusted size of US$ 1076 million by 2031 with a CAGR of 30.2% during the forecast period 2025-2031.
Published Date: 2025-10-16
Pages: 152
USD 3950.00
(Single User License)
The global Organ On Chip market size was US$ 166 million in 2024 and is forecast to a readjusted size of US$ 1076 million by 2031 with a CAGR of 30.2% during the forecast period 2025-2031.
Published Date: 2025-09-08
Pages: 115
USD 4250.00
(Single User License)
The global Organ On Chip market is projected to grow from US$ 166 million in 2024 to US$ 1076 million by 2031, at a CAGR of 30.2% (2025-2031), driven by critical product segments and diverse end‑use applications.
Published Date: 2025-09-08
Pages: 172
USD 4900.00
(Single User License)
In 2024, the global market size of Organ On Chip was estimated to be worth US$ 156 million and is forecast to reach approximately US$ 1019 million by 2031 with a CAGR of 31.2% during the forecast period 2025-2031.
Published Date: 2025-03-28
Pages: 155
USD 5900.00
(Single User License)
The global market for Organ On Chip was estimated to be worth US$ 156 million in 2024 and is forecast to a readjusted size of US$ 1019 million by 2031 with a CAGR of 31.2% during the forecast period 2025-2031.
Published Date: 2025-01-18
Pages: 127
USD 3950.00
(Single User License)
An Organ-On-Chip (OOC) is a multi-channel 3-D microfluidic cell culture chip that simulates the activities, mechanics and physiological response of entire organs and organ systems, a type of artificial organ. It constitutes the subject matter of significant biomedical engineering research, more precisely in bio-MEMS. The convergence of labs-on-chips (LOCs) and cell biology has permitted the study of human physiology in an organ-specific context, introducing a novel model of in vitro multicellular human organisms. One day, they will perhaps abolish the need for animals in drug development and toxin testing. Organ-On-Chip technology not only incorporates multiple cell types but also involves engineering aspects, such as the guided spatial confinement of cells or the incorporation of sensors and microfluidic channels.
Published Date: 2024-01-06
Pages: 131
USD 3950.00
(Single User License)
The global Organ On Chip market is projected to grow from US$ 221 million in 2025 to US$ 1368 million by 2032, at a CAGR of 30.2% (2026-2032), driven by critical product segments and diverse end‑use applications.
Published: 2026-08-15
Pages: 174
The global Organ On Chip market size was US$ 221 million in 2025 and is forecast to reach a readjusted size of US$ 1368 million by 2032 with a CAGR of 30.2% during the forecast period 2026-2032.
Published: 2026-08-15
Pages: 141
The global Organ On Chip market was valued at US$ 221 million in 2025 and is anticipated to reach US$ 1368 million by 2032, at a CAGR of 30.2% from 2026 to 2032.
Published: 2026-08-15
Pages: 160
The global market for Organ On Chip was estimated to be worth US$ 221 million in 2025 and is projected to reach US$ 1368 million, growing at a CAGR of 30.2% from 2026 to 2032.
Published: 2026-08-15
Pages: 147
The global market for Organ On Chip was estimated to be worth US$ 166 million in 2024 and is forecast to a readjusted size of US$ 1076 million by 2031 with a CAGR of 30.2% during the forecast period 2025-2031.
Published: 2025-10-16
Pages: 152
The global Organ On Chip market size was US$ 166 million in 2024 and is forecast to a readjusted size of US$ 1076 million by 2031 with a CAGR of 30.2% during the forecast period 2025-2031.
Published: 2025-09-08
Pages: 115
The global Organ On Chip market is projected to grow from US$ 166 million in 2024 to US$ 1076 million by 2031, at a CAGR of 30.2% (2025-2031), driven by critical product segments and diverse end‑use applications.
Published: 2025-09-08
Pages: 172
In 2024, the global market size of Organ On Chip was estimated to be worth US$ 156 million and is forecast to reach approximately US$ 1019 million by 2031 with a CAGR of 31.2% during the forecast period 2025-2031.
Published: 2025-03-28
Pages: 155
The global market for Organ On Chip was estimated to be worth US$ 156 million in 2024 and is forecast to a readjusted size of US$ 1019 million by 2031 with a CAGR of 31.2% during the forecast period 2025-2031.
Published: 2025-01-18
Pages: 127
An Organ-On-Chip (OOC) is a multi-channel 3-D microfluidic cell culture chip that simulates the activities, mechanics and physiological response of entire organs and organ systems, a type of artificial organ. It constitutes the subject matter of significant biomedical engineering research, more precisely in bio-MEMS. The convergence of labs-on-chips (LOCs) and cell biology has permitted the study of human physiology in an organ-specific context, introducing a novel model of in vitro multicellular human organisms. One day, they will perhaps abolish the need for animals in drug development and toxin testing. Organ-On-Chip technology not only incorporates multiple cell types but also involves engineering aspects, such as the guided spatial confinement of cells or the incorporation of sensors and microfluidic channels.
Published: 2024-01-06
Pages: 131
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now